StonvexLoading…
StonvexStonvexStonvexCore line items from BRZE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-01-31 | Annual 2024 2024-01-31 | Annual 2023 2023-01-31 |
|---|---|---|---|---|
Revenue | $738.18M | $593.41M | $471.80M | $355.43M |
Operating Income | $-144.76M | $-122.16M | $-144.69M | $-148.14M |
Net Income | $-131.29M | $-103.74M | $-129.17M | $-138.97M |
EPS (Diluted) | $-1.22 | $-1.02 | $-1.32 | $-1.47 |
Total Assets | $1.11B | $871.00M | $810.94M | $705.41M |
Total Liabilities | $489.60M | $396.25M | $366.52M | $258.65M |
Cash & Equivalents | $124.34M | $83.06M | $68.23M | $68.59M |
Free Cash Flow OCF − CapEx | $61.85M | $23.45M | $-2.91M | $-37.76M |
Shares Outstanding | 107.91M | 102.19M | 98.10M | 94.57M |